Group 1 - Wabtec's shares increased by 4.9% to $197.96, following a higher-than-average trading volume, contrasting with a 3.6% loss over the past four weeks [1][2] - The stock's recent rise is linked to an agreement with Kazakhstan's national railway for Evolution Series locomotives and long-term service support [2] - Wabtec is expected to report quarterly earnings of $2.27 per share, reflecting a year-over-year increase of 13.5%, with revenues projected at $2.9 billion, up 8.8% from the previous year [2] Group 2 - The consensus EPS estimate for Wabtec has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [4] - Wabtec holds a Zacks Rank of 3 (Hold), similar to Herc Holdings, which also has a Zacks Rank of 3 and reported a 4.5% increase in its stock price [5][6] - Herc Holdings' EPS estimate for the upcoming report is $2.23, representing a significant year-over-year decline of 48.7% [6]

Company Overview - Itron (ITRI) shares increased by 3.7% to $125.07, following a period of 4.9% loss over the past four weeks, indicating a significant trading volume [1] - The company is experiencing steady margin expansion and cash flow despite facing modest top-line pressure [3] Partnership and Product Development - Itron announced a partnership with Current Lighting Solutions to provide a smart lighting solution aimed at enhancing safety, energy efficiency, and operations [2] - The collaboration integrates Itron's CityEdge management technologies with Current's advanced LED fixtures, improving streetlight performance for cities and utilities [2] Financial Performance and Projections - Itron is expected to report quarterly earnings of $1.48 per share, reflecting a year-over-year decline of 19.6%, with revenues projected at $576.45 million, down 6.3% from the previous year [4] - The company's full-year revenue guidance has been reduced to $2.35-$2.4 billion, down from $2.4-$2.5 billion, due to slower project deployments and regulatory complexities [3] Market Sentiment and Stock Performance - The consensus EPS estimate for Itron has been revised slightly lower over the past 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [5] - Itron currently holds a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to other stocks in the same industry [6]

Company Overview - AppLovin (APP) shares increased by 4.5% to $649.59 in the last trading session, with a notable trading volume and a total gain of 48.4% over the past four weeks, driven by investor positioning ahead of its inclusion in the S&P 500 [1] Earnings Expectations - AppLovin is projected to report quarterly earnings of $2.34 per share, reflecting a year-over-year increase of 87.2%. Revenue is expected to reach $1.34 billion, marking an 11.7% rise from the same quarter last year [2] Earnings Estimate Trends - The consensus EPS estimate for AppLovin has remained stable over the last 30 days, indicating that stock price movements may not sustain without changes in earnings estimate revisions. Monitoring AppLovin's performance will be crucial to determine if the recent price increase can lead to further strength [3] Industry Ranking - AppLovin holds a Zacks Rank of 1 (Strong Buy) within the Zacks Technology Services industry, while CoreCard Corporation (CCRD), another company in the same sector, has a Zacks Rank of 3 (Hold) and experienced a 2.2% decline in the last trading session [4][5]

GrafTech International (EAF) shares ended the last trading session 6% higher at $13.46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 35.1% gain over the past four weeks.Per the American Iron and Steel Institute, domestic raw steel production was up 6.5% year over year to 1,764,000 net tons for the week ending on Sept. 13, 2025.  For 2025, domestic steel output is expected to increase modestly, and increased adop ...

Endeavour Silver (EXK) shares rallied 9.4% in the last trading session to close at $6.76. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 9.8% gain over the past four weeks.The company’s shares have gained as gold and silver prices soared to record highs, fueled by rising expectations of additional U.S. Federal Reserve rate cuts. The Fed lowered interest rates by 25 basis points last week and indicated the po ...

Idaho Strategic Resources, Inc. (IDR) shares ended the last trading session 6% higher at $30.91. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 19.7% gain over the past four weeks.The company’s shares have gained as gold prices soared to record highs, fueled by rising expectations of additional U.S. Federal Reserve rate cuts. The Fed lowered interest rates by 25 basis points last week and indicated the potential f ...

Company Overview - Coeur Mining (CDE) shares increased by 7% to close at $17.42, with trading volume significantly higher than usual, reflecting a 39.5% gain over the past four weeks [1][2] Market Conditions - The rise in Coeur Mining's shares is attributed to record-high gold and silver prices, driven by expectations of further U.S. Federal Reserve rate cuts, including a recent 25 basis point reduction [2] - Year-to-date, gold prices have risen by 40.4%, supported by safe-haven buying amid geopolitical tensions and strong central bank purchases, while silver demand is bolstered by industries such as solar, electric vehicles, and electronics [2] Company Performance - Coeur Mining's recent drilling results from its Las Chispas and Kensington mines indicate some of the highest grades, with expected quarterly earnings of $0.22 per share, representing an 83.3% year-over-year increase [3] - Revenue is projected to be $511.2 million, reflecting a 63.1% increase from the same quarter last year [3] Earnings Estimates - The consensus EPS estimate for Coeur Mining has been revised 4.7% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [5] - The company is currently ranked 3 (Hold) by Zacks, while another company in the same industry, United States Antimony Corporation, has a Zacks Rank of 4 (Sell) [6][7]

Company Overview - Rigetti Computing, Inc. (RGTI) shares increased by 12.5% to close at $24.74, with a significant trading volume compared to normal sessions, and a total gain of 49% over the past four weeks [1] - The company is securing new contracts, including a $5.8 million deal with the Air Force and collaboration with India's CDAC, enhancing its client base and growth potential [1] Financial Performance - Rigetti Computing is projected to report a quarterly loss of $0.05 per share, reflecting a year-over-year improvement of 37.5%, with expected revenues of $2.39 million, a slight increase of 0.4% from the previous year [2] - The consensus EPS estimate for Rigetti has remained stable over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] Industry Context - Rigetti Computing operates within the Zacks Internet - Software industry, where another company, BILL Holdings, has also shown positive performance, closing 1.3% higher at $52.59 and achieving a 24.7% return in the past month [3] - BILL Holdings has seen a significant change in its EPS estimate, dropping by 58.5% over the past month to $0.51, which is a 19.1% decrease from the previous year [4]

Core Points - Intellia Therapeutics, Inc. (NTLA) shares increased by 29.8% to $16.11, with a trading volume higher than average, following a 21.6% gain over the past four weeks [1][2] - The stock's rally was driven by the completion of enrollment in the pivotal phase III HAELO study for its investigational candidate, lonvoguran ziclumeran (lonvo-z), aimed at treating hereditary angioedema (HAE) [2] - Top-line data from the HAELO study is anticipated in the first half of 2026, with a potential biologics license application submission planned for the second half of 2026 [3] - If approved, the company intends to launch lonvo-z in the United States in 2027 [3] - The company is projected to report a quarterly loss of $1.01 per share, reflecting a year-over-year increase of 24.6%, while revenues are expected to reach $14.38 million, up 57.8% from the previous year [3] - The consensus EPS estimate for the quarter has been revised 0.5% higher in the last 30 days, indicating a positive trend that may lead to price appreciation [5] - Intellia Therapeutics holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [6] Industry Context - Intellia Therapeutics is part of the Zacks Medical - Biomedical and Genetics industry, which includes other companies like CG Oncology, Inc. (CGON) [6] - CGON's stock closed 2.9% higher at $38.82, with a 47.8% return over the past month, while its consensus EPS estimate has remained unchanged at -$0.57, representing a 90% decrease compared to the previous year [6][7]

Company Overview - Jefferies (JEF) shares increased by 5.8% to close at $70.36, with trading volume significantly higher than usual, reflecting a 12.1% gain over the past four weeks [1][2] - Jefferies has accepted a proposal from Sumitomo Mitsui Financial Group (SMFG) to increase its stake in the investment bank from approximately 15% to nearly 20%, involving an investment of over 100 billion yen [2] Financial Performance - Jefferies is projected to report quarterly earnings of $0.79 per share, representing a year-over-year increase of 5.3%, with expected revenues of $1.89 billion, up 12.4% from the previous year [3] - The consensus EPS estimate for Jefferies has been revised 21.1% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Industry Context - Jefferies is classified under the Zacks Financial - Miscellaneous Services industry, which includes other companies like Blackstone Inc. (BX), that saw a 2.8% increase in its stock price [5] - Blackstone Inc. has a consensus EPS estimate of $1.24, reflecting a 22.8% increase from the previous year, and currently holds a Zacks Rank of 3 (Hold) [6]